Showing results (71-80 of 175) with videos related to

Sort By:
Pageof 18
Frontiers in Pharmacology|October 6, 2025
Dysregulated bile acid metabolism drives lipid peroxidation and ferroptosis in NAFLD: therapeutic potential for traditional Chinese medicineJing Liu, Fuxing Li, Qianru Zeng, et al.
Molecular Pharmaceutics|December 18, 2025
Sialic Acid-Modified Nanoparticles in Combination Therapy with 5-Carboxy-8-hydroxyquinoline: Dual Effects of Intrinsic Blockade of Cellular Escape and Extrinsic Relief of ImmunosuppressionMingze Li, Ruirui Ge, Haidi Zhu, et al.
Drug Delivery and Translational Research|August 30, 2017
Evaluation of the antitumor effects of vitamin K2 (menaquinone-7) nanoemulsions modified with sialic acid-cholesterol conjugateJia Shi, Songlei Zhou, Le Kang, et al.
International Journal of Pharmaceutics|January 3, 2023
Deuterated colchicine liposomes based on oligomeric hyaluronic acid modification enhance anti-tumor effect and reduce systemic toxicityMeng Chen, Shuo Wang, Zhaowei Qi, et al.
AAPS Pharmscitech|April 12, 2022
Polysialic Acid Self-assembled Nanocomplexes for Neutrophil-Based Immunotherapy to Suppress Lung Metastasis of Breast CancerChuizhong Fan, Cong Li, Shuang Lu, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 20, 2016
Evaluation of the antitumor effect of dexamethasone palmitate and doxorubicin co-loaded liposomes modified with a sialic acid-octadecylamine conjugateJing Sun, Yanzhi Song, Mei Lu, et al.
Asian Journal of Pharmaceutical Sciences|February 28, 2020
The effect of monosialylganglioside mix modifying the PEGylated liposomal epirubicin on the accelerated blood clearance phenomenonTing Zhang, Songlei Zhou, Le Kang, et al.
Journal of Liposome Research|January 10, 2024
Sialic acid-modified doxorubicin liposomes target tumor-related immune cells to relieve multiple inhibitions of CD8+ T cellsZhouchunxiao Du, Dezhi Sui, Dongzhe Xin, et al.
Clinical Rheumatology|June 10, 2025
Hyperuricemia is a prognostic marker for antiphospholipid syndrome patients: a retrospective cohort study in ChinaLiang Luo, Qingmeng Cai, Fangning You, et al.
International Journal of Nanomedicine|August 15, 2014
Tolerance-like innate immunity and spleen injury: a novel discovery via the weekly administrations and consecutive injections of PEGylated emulsionsLong Wang, Chunling Wang, Jiao Jiao, et al.
Pageof 18